There is no evidence that fibroids are more common after COVID-19
The premise of your question is not supported by current medical literature. No published research demonstrates a causal relationship between COVID-19 infection and increased incidence of uterine fibroids. The available evidence addresses menstrual disturbances after COVID-19, not fibroid development.
What the Evidence Actually Shows
Menstrual Changes, Not Fibroid Formation
The research on COVID-19's gynecologic impact focuses on menstrual cycle disruptions, not fibroid development:
- Abnormal uterine bleeding occurs in approximately 23% of women post-COVID infection, representing a 2.2-fold increase over baseline 1
- These changes primarily manifest as irregular menstruation, cycle length variations, and flow changes 2, 1
- The mechanisms involve inflammatory responses and hormonal disruption, not tumor formation 2
Association vs. Causation: A Critical Distinction
One literature review mentions that conditions associated with Long COVID (like ME/CFS, POTS, and connective tissue disorders) have higher rates of uterine fibroids 3. However, this represents:
- Pre-existing comorbidities in populations susceptible to chronic illness
- Not new fibroid development caused by COVID-19
- A correlation between chronic inflammatory conditions generally, not COVID-19 specifically
Understanding Fibroid Epidemiology
Global fibroid burden data from 1990-2021 shows no COVID-19-related spike 4:
- Age-standardized prevalence increased minimally (AAPC = 0.05) over 31 years
- Trends correlate with socioeconomic factors, diagnostic improvements, and lifestyle changes
- No acceleration or deviation in 2020-2021 corresponding to the pandemic
Common Pitfall to Avoid
Do not conflate menstrual disturbances with fibroid development. Women experiencing post-COVID menstrual changes (irregular bleeding, heavy periods) may seek evaluation that incidentally detects pre-existing fibroids, creating a false impression of causation. Fibroids develop over months to years through somatic mutations in myometrial cells 5, not acutely following viral infections.
Clinical Approach
If a patient presents concerned about fibroids after COVID-19:
- Reassure that COVID-19 does not cause fibroids
- Evaluate for post-COVID menstrual disturbances if symptomatic (irregular cycles, heavy bleeding, dysmenorrhea)
- Screen for pre-existing abnormal menstruation, which is the strongest risk factor (adjusted OR 39.58) for post-COVID menstrual changes 1
- Image only if clinically indicated by symptoms (heavy bleeding, pelvic pressure, anemia), not based on COVID-19 history alone 6
The question itself reflects a misconception rather than an established medical phenomenon.